Answers are grounded in this paper and cite their sources.
LPS tolerance in all immunological organs studied, without significantly compromising animal welfare. The selective efficacy of dietary β-glucans to counteract immunosuppression, which is often observed in vulnerable and immunocompromised patient populations, warrants further clinical evaluation.
No takes yet. Share an insight, caveat, or question.
Moerings et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: